Moreover, intrahippocampal injection of agmatine (a biogenic amine related to neuroprotection) was able to rescue memory deficits in an acute-AD mouse model induced by intracerebroventricular injection of Aβ1–42, although no differences were observed in APP or BACE-1 expression (35). Here, BACE1 is linked to Alzheimer disease.